Neihulizumab (Anti-PSGL1 / CD162)

Synonyms: ALTB-168

Neihulizumab (Anti-PSGL1 / CD162) is a humanized, agonistic monoclonal antibody against P selectin glycoprotein ligand-1 (PSGL-1, SELPLG, CD162) with potential immunosuppressive activity. It can halt the progression of T-cell-mediated autoimmune diseases and acute graft-versus-host disease (GvHD). MW: 150 kD.

Neihulizumab (Anti-PSGL1 / CD162)

Purity & Quality Control

Batch: A237301 Purity: 99% Protein concentration: 4.51mg/ml Endotoxin Level: <1EU/mg
99

Choose Selective CD markers Inhibitors

Biological Activity

Description Neihulizumab (Anti-PSGL1 / CD162) is a humanized, agonistic monoclonal antibody against P selectin glycoprotein ligand-1 (PSGL-1, SELPLG, CD162) with potential immunosuppressive activity. It can halt the progression of T-cell-mediated autoimmune diseases and acute graft-versus-host disease (GvHD). MW: 150 kD.

Product Details

CAS No. 2158362-38-8
Molecular Weight 150 kDa
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Neihulizumab (Anti-PSGL1 / CD162) | Neihulizumab (Anti-PSGL1 / CD162) supplier | purchase Neihulizumab (Anti-PSGL1 / CD162) | Neihulizumab (Anti-PSGL1 / CD162) cost | Neihulizumab (Anti-PSGL1 / CD162) manufacturer | order Neihulizumab (Anti-PSGL1 / CD162) | Neihulizumab (Anti-PSGL1 / CD162) distributor